Continuing the multiple sclerosis risk sharing scheme is unjustified. (3rd June 2010) - McCabe, Christopher
Abstract : Christopher McCabe and colleagues examine the claims behind the decision not to reduce drug costs in the multiple sclerosis risk sharing scheme